Genenta Science S.p.A.
GNTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $77 | $82 | $94 | $176 |
| - Cash | $5 | $4 | $30 | $37 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $72 | $78 | $64 | $138 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$10 | -$12 | -$11 | -$6 |
| % Margin | – | – | – | – |
| Net Income | -$9 | -$12 | -$8 | -$6 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.49 | -0.64 | -0.47 | -0.31 |
| % Growth | 23.4% | -36.2% | -51.6% | – |
| Operating Cash Flow | -$6 | -$11 | -$7 | -$7 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$6 | -$11 | -$7 | -$7 |